Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30019458HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019459HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30085139HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023974HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023975HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023976HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023977HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20042586HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20027367HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20034731HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB02375
Drug NameMyricetin
Target IDBE0004145
UniProt IDP23458
Regulation Type
PubMed IDs18995957
CitationsKumamoto T, Fujii M, Hou DX: Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett. 2009 Mar 8;275(1):17-26. doi: 10.1016/j.canlet.2008.09.027. Epub 2008 Nov 7.
GroupsExperimental
Direct ClassificationFlavonols
SMILESOC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C(O)=C2)=C1
Pathways
PharmGKB
ChEMBLCHEMBL164